Search results
Showing 4096 to 4110 of 9065 results
Our resource planner tool to help you plan for and implement NICE guidance.
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
NICE's guidance and advice can help you make the best use of resources and generate cost savings.
A range of resources to help healthcare professionals effectively apply NICE guidance to enhance patient care and streamline clinical practices.
Our modular updates framework ensures flexibility and consistency in updating our manuals and helps prioritise important updates.
Should I stop my benzodiazepine or z-drug? This decision aid can help if you have been prescribed a benzodiazepine or z-drug for anxiety or sleeping...
Decision aid for Dementia: assessment, management and support for people living with dementia and their carers c NICE 2018. All rights reserved....
Providing an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care
Science policy projects with NICE.
The EQ-5D is a short questionnaire used to understand how a person’s health affects their quality of life. It is used in health research and to help inform decisions about healthcare treatments.
NICE has implemented new measures to evaluate the cost-effectiveness of medicines, following a policy change that aims to give patients improved access to treatments. This follows the government’s decision to increase the thresholds that NICE can use in technology appraisals to £25,000 to £35,000 per quality-adjusted life year gained.
Find out more about changes to NICE’s cost-effectiveness thresholds and the recent EQ-5D-5L public consultation.
Home What NICE does Our guidance Modular updates {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem"
Over the next year, our prioritisation decisions will be shaped by the government’s strategic direction for health and life sciences, and by the needs of the NHS, local systems and the people who use services.
Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.